SCHEMBL4845543

SCHEMBL4845543

CC(C)CNCC(O)COc1cccc2[nH]ccc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 14/20 0.76
ADRB2 P07550 4/20 0.76
ADRB1 P08588 4/20 0.76
ADRB3 P13945 3/20 0.76
CYP1A2 P05177 2/20 0.76
CYP3A4 P08684 2/20 0.76
LMNA P02545 2/20 0.76
KDM4E B2RXH2 1/20 0.76
USP2 O75604 1/20 0.76
CYP2D6 P10635 1/20 0.76
THRB P10828 1/20 0.76
CYP2C9 P11712 1/20 0.76
TSHR P16473 1/20 0.76
TP53 P04637 1/20 0.76
GLA P06280 1/20 0.76
ALOX15 P16050 1/20 0.76
NFKB1 P19838 1/20 0.76
DRD4 P21917 1/20 0.76
HTR1B P28222 1/20 0.76
HTR2C P28335 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6056296 0.86 HTR1A (0.71) HTR1AADRB2ADRB1ADRB3CYP1A2
Pindolol SCHEMBL29908300 0.86 HTR1A (1.00) HTR1AADRB2ADRB1ADRB3CYP1A2
Pindolol SCHEMBL29379249 0.86 HTR1A (1.00) HTR1AADRB2ADRB1ADRB3CYP1A2
Pindolol SCHEMBL1157882 0.86 HTR1A (1.00) HTR1AADRB2ADRB1ADRB3CYP1A2
Pindolol SCHEMBL1157556 0.86 HTR1A (1.00) HTR1AADRB2ADRB1ADRB3CYP1A2
Pindolol SCHEMBL5219 0.86 HTR1A (1.00) HTR1AADRB2ADRB1ADRB3CYP1A2
Pindolol SCHEMBL5220 0.86 HTR1A (1.00) HTR1AADRB2ADRB1ADRB3CYP1A2
SCHEMBL9450011 0.86 ADRB3 (0.57) HTR1AADRB2ADRB1ADRB3CYP1A2
Pindolol SCHEMBL561162 0.85 HTR1A (0.97) HTR1AADRB2ADRB1ADRB3CYP1A2
Pindolol SCHEMBL2991558 0.85 HTR1A (0.97) HTR1AADRB2ADRB1ADRB3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449480-B2 Small molecule inhibitors of HER2 expression BAYLOR COLLEGE OF MEDICINE (US) 2008-11-11 US disclosed
US-7019017-B2 Small molecule inhibitors of HER2 expression BAYLOR COLLEGE OF MEDICINE (US) 2006-03-28 US disclosed
US-20050288327-A1 Small molecule inhibitors of HER2 expression UESUGI MOTONARI 2005-12-29 US disclosed
US-20050283007-A1 Small molecule inhibitors of HER2 expression BAYLOR COLLEGE OF MEDICINE 2005-12-22 US disclosed
WO-2005074933-A1 SMALL MOLECULE INHIBITORS OF HER2 EXPRESSION BAYLOR COLLEGE OF MEDICINE (US) 2005-08-18 WO disclosed
US-20040006106-A1 Small molecule inhibitors of HER2 expression BAYLOR COLLEGE OF MEDICINE 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050283007-A1 Small molecule inhibitors of HER2 expression ERBB2, ABCC2, SLC2A2 HTR1A 675/4885ADRB2 682/4885ADRB1 1603/4885
US-20050288327-A1 Small molecule inhibitors of HER2 expression ERBB2, ABCC2, SLC2A2 HTR1A 675/4885ADRB2 682/4885ADRB1 1603/4885
US-20040006106-A1 Small molecule inhibitors of HER2 expression ERBB2, EGFR, ABCC2 HTR1A 607/4885ADRB2 654/4885ADRB1 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.